197 related articles for article (PubMed ID: 31829759)
1. Report of a new six-panel flow cytometry marker for early differential diagnosis of APL from HLA-DR negative Non-APL leukemia.
Mosleh M; Mehrpouri M; Ghaffari S; Saei Z; Agaeipoor M; Jadali F; Satlsar ES; Gholampour R
Scand J Clin Lab Invest; 2020; 80(2):87-92. PubMed ID: 31829759
[TBL] [Abstract][Full Text] [Related]
2. The triple-negative (CD34-/HLA-DR-/CD11b-) profile rapidly and specifically identifies an acute promyelocytic leukemia.
Rahman K; Gupta R; Singh MK; Sarkar MK; Gupta A; Nityanand S
Int J Lab Hematol; 2018 Apr; 40(2):144-151. PubMed ID: 28984423
[TBL] [Abstract][Full Text] [Related]
3. The CD9
Ren F; Zhang N; Xu Z; Xu J; Zhang Y; Chen X; Tan Y; Chang J; Wang H
Int J Lab Hematol; 2019 Apr; 41(2):168-175. PubMed ID: 30315692
[TBL] [Abstract][Full Text] [Related]
4. [Immunophenotypic features in 143 cases of acute promyelocytic leukemia].
Sun HM; Qian SX; Wu YJ; Qiao C; Hong M; Fan L; Yang H; Zhang JF; Zhang SJ; Wu HX; Qiu HX; Lu H; Xu W; Sheng RL; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):176-9. PubMed ID: 19236773
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic power of CD117, CD13, CD56, CD64, and MPO in rapid screening acute promyelocytic leukemia.
Tran VT; Phan TT; Mac HP; Tran TT; Ho TT; Pho SP; Nguyen VN; Vo TM; Nguyen HT; Le TT; Vo TH; Nguyen ST
BMC Res Notes; 2020 Aug; 13(1):394. PubMed ID: 32847610
[TBL] [Abstract][Full Text] [Related]
6. [Application of CD123 in detection of minimal residual disease in acute promyelocytic leukemia].
Wang YZ; Chang Y; Zhu HH; Qin YZ; Li JL; Fu JY; Li LD; Chen SS; Huang XJ; Lu DP; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):427-32. PubMed ID: 16800913
[TBL] [Abstract][Full Text] [Related]
7. [Expressions of CD117 and CD11b in patients with APL at diagnosis and post-treatment].
Shen HQ; Tang YM; Song H; Shi SW; Yang SL; Xu WQ; Qian BQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):644-8. PubMed ID: 16928291
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data.
Kaleem Z; Crawford E; Pathan MH; Jasper L; Covinsky MA; Johnson LR; White G
Arch Pathol Lab Med; 2003 Jan; 127(1):42-8. PubMed ID: 12521365
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
[TBL] [Abstract][Full Text] [Related]
10. [Immunophenotypic Analysis of Acute Promyelocytic Leukemia].
Chen F; Hu YP; Wang XH; Fu S; Fu Y; Liu X; Zhang MY; Wang SK; Zhang JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):321-5. PubMed ID: 27150985
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
[TBL] [Abstract][Full Text] [Related]
12. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.
Paietta E; Goloubeva O; Neuberg D; Bennett JM; Gallagher R; Racevskis J; Dewald G; Wiernik PH; Tallman MS;
Cytometry B Clin Cytom; 2004 May; 59(1):1-9. PubMed ID: 15108165
[TBL] [Abstract][Full Text] [Related]
13. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
14. Acute promyelocytic leukemia: four distinct patterns by flow cytometry immunophenotyping.
Gorczyca W
Pol J Pathol; 2012 Mar; 63(1):8-17. PubMed ID: 22535601
[TBL] [Abstract][Full Text] [Related]
15. [Relationship of immunophenotypic features with minimal residual disease detection and gene types in 221 cases of acute promyelocytic leukemia].
Wang YZ; Qin YZ; Jiang B; Zhu HH; Chang Y; Hao L; Li JL; Li LD; Chen SS; Huang XJ; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):271-6. PubMed ID: 19379549
[TBL] [Abstract][Full Text] [Related]
16. CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML.
Satlsar ES; Mosleh M; Mehrpouri M
Turk J Haematol; 2020 Nov; 37(4):287-289. PubMed ID: 32517420
[No Abstract] [Full Text] [Related]
17. A novel flow cytometric method for enhancing acute promyelocytic leukemia screening by multidimensional dot-plots.
Kárai B; Habók M; Reményi G; Rejtő L; Ujfalusi A; Kappelmayer J; Hevessy Z
Ann Hematol; 2019 Jun; 98(6):1413-1420. PubMed ID: 30830246
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR antigen-positive acute promyelocytic leukemia.
Mendoza AS; Qing X; Dungo M; Lasky J; Panosyan E; Cai J
Exp Mol Pathol; 2016 Oct; 101(2):197-200. PubMed ID: 27544027
[TBL] [Abstract][Full Text] [Related]
19. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic pattern of myeloid populations by flow cytometry analysis.
Gorczyca W; Sun ZY; Cronin W; Li X; Mau S; Tugulea S
Methods Cell Biol; 2011; 103():221-66. PubMed ID: 21722806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
